Related Experiment Video
Updated: Dec 7, 2025

09:14
Pre-Chiasmatic, Single Injection of Autologous Blood to Induce Experimental Subarachnoid Hemorrhage in a Rat Model
Published on: June 18, 2021
2.6K
Clinical Relevance of Changes in Peripheral Blood Cells After Intracranial Aneurysm Rupture
Rafal Morga1, Tomasz Dziedzic2, Marek Moskala1
1Department of Neurosurgery and Neurotraumatology, Faculty of Medicine, Jagiellonian University Medical College, Krakow, Poland.
Summary
Intracranial aneurysm rupture triggers significant immune and inflammatory responses. Hematological parameters like the systemic immune-inflammation index (SII) can help assess clinical status and outcomes in patients with ruptured aneurysms.
Area of Science:
- Neuroscience
- Immunology
- Hematology
Background:
- Intracranial aneurysm (IA) rupture elicits a systemic immune and inflammatory reaction.
- Characterizing this systemic response is crucial for understanding patient outcomes.
Purpose of the Study:
- To characterize the systemic immune and inflammatory response following intracranial aneurysm rupture.
- To investigate the clinical utility of hematological parameters in assessing patient status and outcomes.
Main Methods:
- Analyzed mononuclear leukocytes using flow cytometry in 19 acute IA rupture patients and 20 controls.
- Calculated neutrophil-to-lymphocyte ratio (NL-R), lymphocyte-to-monocyte ratio (LM-R), platelet-to-lymphocyte ratio (PL-R), and systemic immune-inflammation index (SII).
- Correlated hematological parameters with clinical status (Glasgow Coma Scale, Hunt and Hess scale) and outcomes.
Main Results:
- Ruptured IA patients showed higher white blood cells, neutrophils, NL-R, and SII, with lower lymphocytes and LM-R compared to controls.
- Poor clinical status correlated with lower lymphocyte counts and higher NL-R, PL-R, and SII.
- Worse outcomes were associated with lower lymphocyte counts and higher PL-R.
Conclusions:
- Systemic immune and inflammatory responses are significant after IA rupture.
- Hematological parameters offer potential clinical utility for assessing IA rupture severity and outcomes.
- Further investigation into DN T cells and SII as clinical markers is warranted.

